Globus Medical Inc (GMED)
84.72
-0.19
(-0.22%)
USD |
NYSE |
Nov 22, 16:00
84.72
0.00 (0.00%)
Pre-Market: 20:00
Globus Medical Cash from Financing (Quarterly): 19.58M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 19.58M |
| June 30, 2024 | 8.709M |
| March 31, 2024 | -115.72M |
| December 31, 2023 | -237.27M |
| September 30, 2023 | 1.425M |
| June 30, 2023 | 1.084M |
| March 31, 2023 | 2.94M |
| December 31, 2022 | 13.59M |
| September 30, 2022 | 13.16M |
| June 30, 2022 | -142.76M |
| March 31, 2022 | 6.047M |
| December 31, 2021 | -1.023M |
| September 30, 2021 | 22.68M |
| June 30, 2021 | 24.93M |
| March 31, 2021 | 7.564M |
| December 31, 2020 | 27.21M |
| September 30, 2020 | 23.68M |
| June 30, 2020 | -20.89M |
| March 31, 2020 | -68.67M |
| December 31, 2019 | 11.18M |
| September 30, 2019 | 6.619M |
| June 30, 2019 | 1.73M |
| March 31, 2019 | 4.905M |
| December 31, 2018 | 2.838M |
| September 30, 2018 | 2.551M |
| Date | Value |
|---|---|
| June 30, 2018 | 23.31M |
| March 31, 2018 | 3.867M |
| December 31, 2017 | -0.083M |
| September 30, 2017 | 1.032M |
| June 30, 2017 | 3.688M |
| March 31, 2017 | -3.011M |
| December 31, 2016 | -3.558M |
| September 30, 2016 | 0.853M |
| June 30, 2016 | 1.58M |
| March 31, 2016 | 1.595M |
| December 31, 2015 | -1.109M |
| September 30, 2015 | 1.654M |
| June 30, 2015 | 1.923M |
| March 31, 2015 | 1.809M |
| December 31, 2014 | 2.158M |
| September 30, 2014 | 0.916M |
| June 30, 2014 | 3.431M |
| March 31, 2014 | 6.441M |
| December 31, 2013 | 1.271M |
| September 30, 2013 | 3.999M |
| June 30, 2013 | 4.953M |
| March 31, 2013 | 0.788M |
| December 31, 2012 | 0.172M |
| September 30, 2012 | 23.92M |
| June 30, 2012 | 0.125M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-237.27M
Minimum
Dec 2023
27.21M
Maximum
Dec 2020
-20.13M
Average
6.806M
Median
Cash from Financing (Quarterly) Benchmarks
| Boston Scientific Corp | 7.00M |
| Haemonetics Corp | -74.80M |
| ResMed Inc | -150.76M |
| AngioDynamics Inc | -0.509M |
| Stryker Corp | 2.653B |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 203.65M |
| Cash from Investing (Quarterly) | -14.97M |
| Free Cash Flow | 293.77M |
| Free Cash Flow Per Share (Quarterly) | 1.171 |
| Free Cash Flow to Equity (Quarterly) | 155.04M |
| Free Cash Flow to Firm (Quarterly) | 162.41M |
| Free Cash Flow Yield | 2.53% |